Evidence map›Paper›PMID 25624720›Full record

ArticleWorld journal of gastroenterology2015

NOB1 is essential for the survival of RKO colorectal cancer cells.

Xiao-Wen He, Tao Feng, Qiao-Ling Yin, Yuan-Wei Jian, Ting Liu

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiao-Wen HeXiao-Wen He, Tao Feng, Qiao-Ling Yin, Department of General Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zheijiang University, Shaoxing 312000, Zhejiang Province, China.
Tao FengXiao-Wen He, Tao Feng, Qiao-Ling Yin, Department of General Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zheijiang University, Shaoxing 312000, Zhejiang Province, China.
Qiao-Ling YinXiao-Wen He, Tao Feng, Qiao-Ling Yin, Department of General Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zheijiang University, Shaoxing 312000, Zhejiang Province, China.
Yuan-Wei JianXiao-Wen He, Tao Feng, Qiao-Ling Yin, Department of General Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zheijiang University, Shaoxing 312000, Zhejiang Province, China.
Ting LiuXiao-Wen He, Tao Feng, Qiao-Ling Yin, Department of General Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zheijiang University, Shaoxing 312000, Zhejiang Province, China.
Shaoxing People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the role of NOB1, a regulator of cell survival in yeast, in human colorectal cancer cells.

methodsLentivirus-mediated small interfering RNA (siRNA) was used to inhibit NOB1 expression in RKO human colorectal cancer cells in vitro and in vivo in a mouse xenograft model. The in vitro and in vivo knockdown efficacy was determined using both Western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR). qRT-PCR was also used to analyze the downstream signals following NOB1 knockdown. Cell growth and colony formation assays were used to determine the effect of NOB1 inhibition on RKO proliferation and their ability to form colonies. Endonuclease activity, as evaluated by terminal deoxytransferase-mediated dUTP nick end labeling (TUNEL), and annexin V staining were used to determine the presence of apoptotic cell death prior to and following NOB1 inhibition. Cell cycle analysis was used to determine the effect of NOB1 inhibition on RKO cell cycle. A cDNA microarray was used to determine global differential gene expression following NOB1 knockdown.

resultsVirus-mediated siRNA inhibition of NOB1 resulted in (1) the down-regulation of NOB1 expression in RKO cells for both the mRNA and protein; (2) inhibition of NOB1 expression both in vitro and in vivo experimental systems; (3) cell growth inhibition via significant induction of cell apoptosis, without alteration of the cell cycle distribution; and (4) a significant decrease in the average weight and volume of xenograft tumors in the NOB1-siRNA group compared to the control scr-siRNA group (P = 0.001, P < 0.05). Significantly more apoptosis was detected within tumors in the NOB1-siRNA group than in the control group. Microarray analysis detected 2336 genes potentially regulated by NOB1. Most of these genes are associated with the WNT, cell proliferation, apoptosis, fibroblast growth factor, and angiogenesis signaling pathways, of which BAX and WNT were validated by qRT-PCR. Among them, 1451 probes, representing 963 unique genes, were upregulated; however, 2308 probes, representing 1373 unique genes, were downregulated.

conclusionNOB1 gene silencing by lentivirus-mediated RNA interference can inhibit tumor growth by inducing apoptosis of cancerous human colorectal cells.

Indexed as

AnimalsApoptosisCarcinomaCell CycleCell Line, TumorCell ProliferationCell SurvivalColorectal NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic TherapyGenetic VectorsHumansLentivirusMice, NudeNOB1 protein, humanNuclear ProteinsRNA-Binding ProteinsApoptosisBAXColorectal cancerNOB1Small RNA interferenceWNT

Identifiers

PMID25624720
PMCPMC4299339
OpenAlexW2360421760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.